BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37832859)

  • 1. IUPHAR review - Data-driven computational drug repurposing approaches for opioid use disorder.
    Gao Z; Ding P; Xu R
    Pharmacol Res; 2024 Jan; 199():106960. PubMed ID: 37832859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine-learning repurposing of DrugBank compounds for opioid use disorder.
    Feng H; Jiang J; Wei GW
    Comput Biol Med; 2023 Jun; 160():106921. PubMed ID: 37178605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repurposing for opioid use disorders: integration of computational prediction, clinical corroboration, and mechanism of action analyses.
    Zhou M; Wang Q; Zheng C; John Rush A; Volkow ND; Xu R
    Mol Psychiatry; 2021 Sep; 26(9):5286-5296. PubMed ID: 33432189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine-learning Repurposing of DrugBank Compounds for Opioid Use Disorder.
    Feng H; Jiang J; Wei GW
    ArXiv; 2023 Mar; ():. PubMed ID: 36911277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
    Pergolizzi JV; Raffa RB; Rosenblatt MH
    J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing: a promising tool to accelerate the drug discovery process.
    Parvathaneni V; Kulkarni NS; Muth A; Gupta V
    Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
    Jain P; Jain SK; Jain M
    Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of Opioid Use Disorder-Update and Current Challenges.
    Racha S; Buresh M; Fingerhood M
    Psychiatr Clin North Am; 2022 Sep; 45(3):335-346. PubMed ID: 36055727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Data-driven drug discovery for drug repurposing].
    Saito R; Yano N; Kojima S; Miyoshi F
    Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
    Morgan JR; Schackman BR; Leff JA; Linas BP; Walley AY
    J Subst Abuse Treat; 2018 Feb; 85():90-96. PubMed ID: 28733097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.
    Rani N; Kaushik A; Kardam S; Kag S; Raj VS; Ambasta RK; Kumar P
    Prog Mol Biol Transl Sci; 2024; 205():23-70. PubMed ID: 38789181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder.
    Lee YK; Gold MS; Fuehrlein BS
    J Neurol Sci; 2022 Jan; 432():120094. PubMed ID: 34933249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing: Iron in the fire for older drugs.
    Sonaye HV; Sheikh RY; Doifode CA
    Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
    Chalhoub RM; Kalivas PW
    Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Appraisal of Using Opioids in Patients with Opioid Use Disorder.
    Smith RG
    J Am Podiatr Med Assoc; 2023; 113(3):. PubMed ID: 37463194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of biologics and biopharmaceuticals.
    Israr J; Alam S; Singh V; Kumar A
    Prog Mol Biol Transl Sci; 2024; 205():277-302. PubMed ID: 38789184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.